115 related articles for article (PubMed ID: 10687725)
1. Update on the biology of chronic lymphocytic leukemia.
Bannerji R; Byrd JC
Curr Opin Oncol; 2000 Jan; 12(1):22-9. PubMed ID: 10687725
[TBL] [Abstract][Full Text] [Related]
2. Increased cytotoxicity against B-chronic lymphocytic leukemia by cellular manipulations: potentials for therapeutic use.
Vu UE; Pavletic ZS; Wang X; Joshi SS
Leuk Lymphoma; 2000 Nov; 39(5-6):573-82. PubMed ID: 11342340
[TBL] [Abstract][Full Text] [Related]
3. Argyrophilic nucleolar organizer regions (AgNORs) in relation to p53 and bcl-2 protein expression in leukemia patients.
Klobusická M; Kusenda J; Babusíková O
Neoplasma; 2003; 50(6):408-15. PubMed ID: 14689061
[TBL] [Abstract][Full Text] [Related]
4. Molecular biology of chronic lymphocytic leukemia.
Reed JC
Semin Oncol; 1998 Feb; 25(1):11-8. PubMed ID: 9482522
[TBL] [Abstract][Full Text] [Related]
5. Good prognosis cytogenetics in B-cell chronic lymphocytic leukemia is associated in vitro with low susceptibility to apoptosis and enhanced immunogenicity.
Jahrsdörfer B; Wooldridge JE; Blackwell SE; Taylor CM; Link BK; Weiner GJ
Leukemia; 2005 May; 19(5):759-66. PubMed ID: 15759034
[TBL] [Abstract][Full Text] [Related]
6. Chronic lymphocytic leukemia.
Kipps TJ
Curr Opin Hematol; 1998 Jul; 5(4):244-53. PubMed ID: 9747630
[TBL] [Abstract][Full Text] [Related]
7. Surface antigen expression and correlation with variable heavy-chain gene mutation status in chronic lymphocytic leukemia.
Vilpo J; Tobin G; Hulkkonen J; Hurme M; Thunberg U; Sundström C; Vilpo L; Rosenquist R
Eur J Haematol; 2003 Jan; 70(1):53-9. PubMed ID: 12631259
[TBL] [Abstract][Full Text] [Related]
8. B-cell receptor configuration and mutational analysis of patients with chronic lymphocytic leukaemia and trisomy 12 reveal recurrent molecular abnormalities.
Falisi E; Novella E; Visco C; Guercini N; Maura F; Giaretta I; Pomponi F; Nichele I; Finotto S; Montaldi A; Neri A; Rodeghiero F
Hematol Oncol; 2014 Mar; 32(1):22-30. PubMed ID: 23861036
[TBL] [Abstract][Full Text] [Related]
9. Chronic lymphocytic leukemia: a clinical and molecular heterogenous disease.
Rodríguez-Vicente AE; Díaz MG; Hernández-Rivas JM
Cancer Genet; 2013 Mar; 206(3):49-62. PubMed ID: 23531595
[TBL] [Abstract][Full Text] [Related]
10. p53 Aberrations do not predict individual response to fludarabine in patients with B-cell chronic lymphocytic leukaemia in advanced stages Rai III/IV.
Valgañón M; Giraldo P; Agirre X; Larráyoz MJ; Rubio-Martinez A; Rubio-Felix D; Calasanz MJ; Odero MD
Br J Haematol; 2005 Apr; 129(1):53-9. PubMed ID: 15801955
[TBL] [Abstract][Full Text] [Related]
11. Surface antigen expression in chronic lymphocytic leukemia: clustering analysis, interrelationships and effects of chromosomal abnormalities.
Hulkkonen J; Vilpo L; Hurme M; Vilpo J
Leukemia; 2002 Feb; 16(2):178-85. PubMed ID: 11840283
[TBL] [Abstract][Full Text] [Related]
12. Genetics, gene expression, and targeted therapies in chronic lymphocytic leukemia.
Winkler D; Döhner H; Stilgenbauer S
Curr Drug Targets; 2006 Oct; 7(10):1313-27. PubMed ID: 17073593
[TBL] [Abstract][Full Text] [Related]
13. Silencing of APAF-1 in B-CLL results in poor prognosis in the case of concomitant p53 mutation.
Sturm I; Bosanquet AG; Radetzki S; Hummel M; Dörken B; Daniel PT
Int J Cancer; 2006 May; 118(9):2329-36. PubMed ID: 16331630
[TBL] [Abstract][Full Text] [Related]
14. Lack of extensive mutations in the VH5 genes used in common B cell chronic lymphocytic leukemia.
Rassenti LZ; Kipps TJ
J Exp Med; 1993 Apr; 177(4):1039-46. PubMed ID: 7681468
[TBL] [Abstract][Full Text] [Related]
15. Drug-induced apoptosis in B-cell chronic lymphocytic leukemia: relationship between p53 gene mutation and bcl-2/bax proteins in drug resistance.
Thomas A; El Rouby S; Reed JC; Krajewski S; Silber R; Potmesil M; Newcomb EW
Oncogene; 1996 Mar; 12(5):1055-62. PubMed ID: 8649796
[TBL] [Abstract][Full Text] [Related]
16. 11q22.3 deletion in B-chronic lymphocytic leukemia is specifically associated with bulky lymphadenopathy and ZAP-70 expression but not reduced expression of adhesion/cell surface receptor molecules.
Dickinson JD; Gilmore J; Iqbal J; Sanger W; Lynch JC; Chan J; Bierman PJ; Joshi SS
Leuk Lymphoma; 2006 Feb; 47(2):231-44. PubMed ID: 16321852
[TBL] [Abstract][Full Text] [Related]
17. miR-181a/b significantly enhances drug sensitivity in chronic lymphocytic leukemia cells via targeting multiple anti-apoptosis genes.
Zhu DX; Zhu W; Fang C; Fan L; Zou ZJ; Wang YH; Liu P; Hong M; Miao KR; Liu P; Xu W; Li JY
Carcinogenesis; 2012 Jul; 33(7):1294-301. PubMed ID: 22610076
[TBL] [Abstract][Full Text] [Related]
18. The immunoglobulin genes and chronic lymphocytic leukemia (CLL).
Tobin G
Ups J Med Sci; 2005; 110(2):97-113. PubMed ID: 16075892
[TBL] [Abstract][Full Text] [Related]
19. bcl-2 rearrangement detected by pulsed-field gel electrophoresis (PFGF) in B-chronic lymphocytic leukemia (CLL) cells.
Laytragoon-Lewin N; Kashuba V; Mellstedt H; Klein G
Int J Cancer; 1998 Jun; 76(6):909-12. PubMed ID: 9626361
[TBL] [Abstract][Full Text] [Related]
20. Chronic lymphocytic leukaemia: an immunobiology approach.
Kostareli E; Smilevska T; Stamatopoulos K; Kouvatsi A; Anagnostopoulos A
Srp Arh Celok Lek; 2008; 136(5-6):319-23. PubMed ID: 18792635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
